1-7 of 7
Laure Moutouh-de Parseval
Close
Sort by
Journal Articles

A First-in-Human Study of YTB323, a Novel, Autologous CD19-Directed CAR-T Cell Therapy Manufactured Using the Novel T-Charge TM platform, for the Treatment of Patients (Pts) with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL)

Ian W. Flinn, Ulrich Jaeger, Nirav N. Shah, Didier Blaise, Javier Briones, Leyla Shune, Nicolas Boissel, Attilio Bondanza, Darlene Lu, Xu Zhu, Boris Engels, Jennifer L Brogdon, Jennifer Mataraza, Jaclyn Davis, Anne Laure Marchal, Luisa Mariconti, Michele Moschetta, Laure Moutouh-de Parseval, Pere Barba, Michael Dickinson
Journal: Blood
Blood (2021) 138 (Supplement 1): 740.
https://doi.org/10.1182/blood-2021-146268
Published: 2021
Journal Articles

Final Results of the Phase I Study of Lenalidomide In Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL-001 Study)

Clemens Wendtner, Peter Hillmen, MBChB, FRCP, FRCPath, PhD, Daruka Mahadevan, MD, PhD, Stephan Stilgenbauer, M.D., Lutz Uharek, Steven Coutre, Olga Frankfurt, Adrian Bloor, PhD, MRCP, FRCPath, Francesc Bosch, MD, PhD, Richard R. Furman, MD, Eva Kimby, John G. Gribben, MD, DSc, Marco Gobbi, MD, Luke Dreisbach, MD, David Duane Hurd, MD, Mikkael A. Sekeres, MD, MS, Alessandra Ferrajoli, MD, Sheetal Shah, Jennie Zhang, Laure Moutouh de Parseval, MD, Asher A. Chanan-Khan
Journal: Blood
Blood (2010) 116 (21): 1376.
https://doi.org/10.1182/blood.V116.21.1376.1376
Published: 2010
Journal Articles

Pomalidomide Modifies Sickle Cell Related Organ Damage in Transgenic Mice with Sickle Cell Anemia.

Steffen E. Meiler, MD, Marlene Wade, Laure Moutouh de Parseval, MD, Laura G Corral, Paul S. Swerdlow, MD, Ferdane Kutlar, MD, Abdullah Kutlar
Journal: Blood
Blood (2009) 114 (22): 904.
https://doi.org/10.1182/blood.V114.22.904.904
Published: 2009
Journal Articles

Targeting the p27 E3 ligase SCF Skp2 results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy

Qing Chen, Weilin Xie, Deborah J. Kuhn, Peter M. Voorhees, Antonia Lopez-Girona, Derek Mendy, Laura G. Corral, Veronique Plantevin Krenitsky, Weiming Xu, Laure Moutouh-de Parseval, David R. Webb, Frank Mercurio, Keiichi I. Nakayama, Keiko Nakayama, Robert Z. Orlowski
Journal: Blood
Blood (2008) 111 (9): 4690–4699.
https://doi.org/10.1182/blood-2007-09-112904
Published: 2008
Includes: Supplemental data
Journal Articles

Lenalidomide and CC-4047 Inhibit the Proliferation of Namalwa Cancer Cells While Expanding CD34 + Progenitor Cells. New Insights on the Combination Therapy with Certain HDAC Inhibitors for Hematological Cancers.

Dominique Verhelle, PhD, Laura G. Corral, MS, Kevin Wong, BS, Jessica H. Mueller, MS, Laure Moutouh de Parseval, MD, Kristen Jensen-Pergakes, MS, Emilia Glezer, MS, Gregory D. Ferguson, PhD, Helen A. Brady, PhD
Journal: Blood
Blood (2006) 108 (11): 1120.
https://doi.org/10.1182/blood.V108.11.1120.1120
Published: 2006
Journal Articles

Lenalidomide and Novel Immunomodulatory Drugs (IMiDs®): A New Approach to the Regulation of Erythropoiesis and Hemoglobin Synthesis in Anemia.

Laure Moutouh de Parseval, MD, Helen Brady, Ph.D, Dominique Verhelle, PhD, Laura G. Corral, MS, Emilia Glezer, BS, Christopher L. Morris, MD, PhD, Roger Chen, PhD, Kyle Chan, PhD
Journal: Blood
Blood (2005) 106 (11): 2702.
https://doi.org/10.1182/blood.V106.11.2702.2702
Published: 2005
Journal Articles

Novel Immunomodulatory Drugs (IMiDs®): A Potential, New Therapy for β-Hemoglobinopathies.

Laure Moutouh de Parseval, MD., Helen Brady, PhD., Emila Glezer, MS., Normand Richard, MS., George Muller, PhD., Christopher L. Morris, MD., PhD., Dave Stirling, PhD., Kyle Chan, PhD.
Journal: Blood
Blood (2004) 104 (11): 3740.
https://doi.org/10.1182/blood.V104.11.3740.3740
Published: 2004